Therefore, NKG2D CAR NK cells that did not directly target neuroblastoma cells due to their lack of NKG2D ligand contributed to limiting tumor growth by eliminating NKG2D+ MDSCs and increasing infiltration of neuroblastoma-targeting CAR T cells [261]. The gene discussed is KLRK1; the disease is neoplasm.